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Abstract
Background: There are no nationwide studies documenting changes in cutaneous malignant melanoma incidence
or association of incidence with socioeconomic status (SES) in Canada. We sought to determine whether melanoma
incidence increased from 1992 to 2006 and if there was an association between SES and melanoma incidence.
Additionally, we studied whether there was a correlation between province of residence and melanoma incidence.
Methods: Cases from the Canadian Cancer Registry were reviewed. Demographic and socioeconomic information
were extracted from the Canadian Census of Population data. Cases were linked to income quintiles by postal code. A
negative binomial regression was performed to identify relationships among these variables.
Results: Overall incidence of melanoma in Canada increased by 67 % from 1992 to 2006 (p < 0.0001). The increase in
incidence was greater for melanoma in situ compared with invasive melanoma (136 % versus 52 % [p < 0.0001]).
Incidence was positively correlated with higher income quintiles; the incidence rates among patients in the lowest
income quintiles were 67 % of that for the highest income quintiles (p < 0.0001).
Discussion: A wide variety of explanations have been postulated for an increased incidence in melanoma among
persons of higher SES, including access to and awareness of screening, more access to vacations in sunny climates, and
increased leisure time. Variations in incidence of melanoma by urban vs. rural location and province may indicate
differences in access to dermatologists across Canada.
Conclusions: Melanoma incidence is increasing in Canada and is higher among people in high SES groups. This rise is
likely due to a combination of factors including a true rise in incidence due to increases in sun exposure, and also an
increased detection rate, particularly in those who are more aware of the disease and have access to resources for
detection.
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Background
Worldwide incidence of cutaneous malignant melanoma
(hereafter referred to as ‘melanoma’) has continued to
rise over the past several decades, with about 160,000
new cases diagnosed each year in the United States
alone [1–3]. Most of the increased incidence has oc-
curred in countries with predominately fair-skinned
people. The countries with the highest incidence include
Australia [4], New Zealand [5], Western European
countries [6] and North American countries [7, 8].
Though melanoma is less common than other skin can-
cers, it causes 75 % of deaths from skin cancer [2].
Ongoing depletion of the ozone layer and increased
solar ultraviolet radiation reaching the earth’s surface is
causing a continued rise in skin cancer incidence. The
World Health Organization estimates that there is an in-
crease of 4500 skin cancer cases for each 10 % decrease
in ozone levels [1]. The risk of melanoma is associated
with increases in sun holidays [9, 10] and use of indoor
tanning beds [11, 12]. Earlier detection of thinner mela-
nomas accounts for a substantial proportion of the in-
crease in melanoma incidence [13–15]. This can likely
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be explained by improved education and screening strat-
egies [16]. As melanoma results from cumulative expos-
ure to the sun, people have more time to accumulate
sun damage and subsequent cancers with increased lon-
gevity [17, 18].
Socioeconomic status (SES) is known to be associated
with both melanoma incidence and survival [10, 19–21].
High SES is associated with increased incidence of mel-
anoma, thinner tumors, increased survival and decreased
mortality [19–21]. Singh et al. examined the incidence of
cutaneous melanoma in the United States by merging
population-based central cancer registries with county-
level SES estimates from the U.S. Census Bureau [21].
They found that counties with lower poverty, higher
education, higher income and lower unemployment had
higher age-adjusted melanoma incidence rates for early
stage disease [21]. Similarly, Perez-Gomez et al. exam-
ined the association of SES and melanoma in Sweden
using the Swedish Cancer Environment Registry and the
Background Population Registry, which contain informa-
tion on occupation, residence and date of death [20].
They used these data to determine association between
SES (using occupation as a proxy) and melanoma and
found a marked increase in the risk of melanoma in
white-collar workers, particularly for men [20]. Other
studies have yielded similar results. Theories explaining
the increased incidence of melanoma among higher SES
individuals include intense intermittent ultraviolet ex-
posure (sun holidays) [20] and increased knowledge of
and access to screening [16]. The reason for decreased
mortality in this group may be related to an earlier stage
at diagnosis [16].
Haider et al. used a population-based, cross-sectional
study of administrative health care databases in a single
Canadian province (Ontario) to determine if there was
an association between melanoma prevalence and in-
come level (used as a proxy for SES) [22]. They found an
increased prevalence of 225 % in the highest compared
with the lowest income groups. The Western Canada
Melanoma study was performed by Gallagher et al. to
determine the association between SES and risk of mel-
anoma in four Canadian provinces (British Columbia,
Alberta, Saskatchewan and Manitoba) [23]. Their study
consisted of a detailed, multivariate analysis of 261 male
cases as well as age- and sex-matched controls, using
usual occupation as their proxy for SES. In their univari-
ate analysis they found a strong positive association be-
tween SES and risk of melanoma. However, using
multivariate analysis, they found that this association
was substantially explained by host constitutional factors
and sunlight exposure.
There has been conflicting evidence in the literature
regarding how urban or rural residence affects the inci-
dence of melanoma. Aase et al. used Norwegian Cancer
Registry data from 1955 to 1989 and found urban resi-
dence to be associated with high melanoma incidence
[24]. Conversely, Wesseling et al. analyzed the Costa
Rica Cancer Registry data from 1981 to 1993 and found
an increase in melanoma incidence in rural areas [25].
Perez-Gomez et al. also included an analysis of melan-
oma incidence by urban versus rural place of residence
[20]. They found that there was an increased risk in men
living in larger towns. The pattern for women living in
urban areas showed an increase only in melanomas of
the leg. Increase in intermittent sun exposure (a known
significant risk factor for melanoma) and, perhaps, im-
proved access to health care for screening and detection
may cause increased incidence [20].
To our knowledge, there has not been a Canadian study
using nationwide Cancer Registry data to examine the re-
lationship between melanoma cancer incidence, SES and
geographic location in Canada. The purpose of this study
was to determine whether there was an increased inci-
dence of melanoma in Canada from 1992 to 2006 and if
there was an association between SES and incidence. Add-
itionally, we studied whether there was an association be-
tween urban versus rural residence and incidence of
melanoma and if there was a correlation between province
of residence and incidence of cutaneous melanoma.
Methods
Data for this study were extracted from the Canadian
Cancer Registry data file and the Canadian Census of
Population from Statistics Canada. The registry data file
contains patient demographic and tumor-specific infor-
mation on each tumor included in provincial and terri-
torial cancer registries from 1992 to 2006 inclusively,
while the census files provide neighborhood-level (dis-
semination area, DA) data on age/sex composition, aver-
age household income and location of residence. The
reason that newer data is not included is due to the fact
that 2006 is the last year that the long form census was
used. Data sources, the methods employed to generate
income quintiles and demographic characteristics, and
the methods used to construct the dataset for estimation
have been described in detail elsewhere [26, 27]. Since
census data are available only every 5 years, cases diag-
nosed in 1992–1995 were associated with data from the
1991 census year (CY); cases diagnosed in the 1996–
2000 period, the 1996 CY; cases diagnosed in the 2001–
2005 period, the 2001 CY; and cases diagnosed in the
2006–2007 period, the 2006 CY. The number of DAs for
which census information was available was 32,825 in
1991, 38,016 in 1996, 46,909 in 2001 and 52,443 in 2006.
Income quintile (InQ) for each DA was defined relative
to other DAs in the associated census division, which
Statistics Canada defines as a group of neighboring mu-
nicipalities joined together for the purposes of regional
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planning and managing of common services. Dissemin-
ation areas within each census division were sorted by
average household income then assigned to one of five
InQs. All analysis was within the University of New Bruns-
wick Research Data Centre (NB-RDC) and all output was
vetted for release using enhanced vetting methods re-
quired by Statistics Canada. Ethics approval is not required
for research projects using data stored in the NB-RDC.
For each CY, the unit of observation for the analysis of
incidence was the DA, and the key variable of interest
was the number of cases of melanoma (International
Classification of Diseases codes: O2/3 C44.0-C44.9), in-
cluding both malignant melanoma and melanoma in
situ, diagnosed in adults over the age of 18 in each DA
over a relevant period of time corresponding to the CY.
Unfortunately, data on in situ melanoma cases are not
available for Ontario in the data provided by Statistics
Canada, which necessitates estimation of the main
model for a number of alternative sample specifications.
These include: 1) all cases of melanoma, invasive melan-
oma and in situ melanoma for all provinces and territor-
ies except Ontario and 2) invasive melanoma for all
provinces and territories including Ontario.
The exposure variable was the adult population in the
DA during the CY multiplied by the number of years in
the corresponding time interval for that census (2, 4 or
5 years). Negative binomial regression models were esti-
mated where neighborhood SES, as measured by the
InQ of the DA, was captured by a 0/1 binary variable for
each InQ, with the highest InQ specified as the baseline.
Indicator variables for each CY from 1996 to 2006 with
1991 as the reference year were included to reflect
changes over time. The regressions also included indica-
tor variables for province of residence of the individual
at the time of diagnosis as well as whether the DA of
residence was a larger urban center (census metropolitan
area with a total population of at least 100,000 of which
50,000 or more must live in an urban core), smaller
urban center (census agglomeration with a total popula-
tion of between 10,000 and 100,000) and rural, if the DA
was not located in either a census metropolitan area or
census agglomeration.
To control for differences in the ethnic/racial compos-
ition across DA populations and over time, the total
adult population in each DA that identify as 1) black, 2)
south Asian, 3) east Asian and 4) other visible minority
group were extracted from each census file. Each of
these measures was included as controls in the analysis.
Results
Incidence by census year
Using multivariate regression, the incidence of invasive
melanoma increased with time over the study period of
CY 1991 to CY 2006 after controlling for age, sex and race
(Table 1). For invasive melanoma (excluding Ontario) the
incidence rate ratio (IRR) increased from 1.0 in the refer-
ence CY (1991) to 1.52 in the 2006 CY (IRR 1.52, p <
0.000, 95 % confidence interval [CI] 1.46–1.59). Most of
the increase in incidence occurred between the 2001 and
2006 CYs (IRR 2001 1.05, p < 0.00), 95 % CI 1.01–1.09).
The results were not materially different when Ontario
was included in the analysis. For melanoma in situ, a simi-
lar but more pronounced pattern of increasing IRRs with
later CYs was identified, with the 2006 CY showing an in-
cidence rate 136 % greater than the 1991 CY (IRR 2.36,
p < 0.000, 95 % CI 2.17–2.57). Table 2 displays the
multivariate analysis regression results broken down by
controls for the age/sex composition of the DA as well
as controls for the various race proportions in the DA.
Incidence by socioeconomic status
Table 1 shows that, for invasive melanoma, individuals
in the lowest InQ had an incidence rate that was 82 % of
the incidence rate of individuals in the highest InQ (IRR
0.82, p < 0.000, 95 % CI 0.78–0.85) after controlling for
age, sex and race distribution and other factors. A simi-
lar, but stronger, association existed for melanoma in
situ; again, a progressively lower incidence rate ratio was
identified for progressively lower InQs, with the lowest
InQ having an incidence rate that was 68 % of that for
the highest InQ (IRR 0.68, p < 0.000, 95 % CI 0.62–0.73).
The analysis was repeated with the Ontario data and
showed no significant difference from the results exclud-
ing Ontario. In the first column of results from Table 1,
determinants of the diagnosis of both invasive and in situ
melanoma for all provinces and territories except Ontario
(as in situ data was not available for Ontario) were esti-
mated. Progressively lower InQs were associated with a
progressively lower diagnosis of melanoma and the IRR of
each InQ relative to the highest was significantly <1.
Incidence by province of residence
There were wide disparities in the incidence rate of mel-
anoma across the various provinces of Canada, as seen
in Table 1. British Columbia was used as the reference
province. Ontario was omitted to facilitate comparisons
between in situ and invasive melanoma (only results for
invasive melanoma in Ontario were available). Again,
age, sex and race were controlled for multivariate regres-
sion analysis. For invasive melanoma, several provinces
had IRRs that were significantly less than for British
Columbia, with the most significant difference occurring
in the province of Quebec, with an incidence rate only
44 % of that for the reference province (IRR 0.44,
p < 0.000, 95 % CI 0.42–0.45). Other provinces with
significantly lower IRRs included Newfoundland (IRR
0.66, p < 0.000, 95 % CI 0.61–0.71), Manitoba (IRR 0.74,
p < 0.000, 95 % CI 0.70–0.78), Saskatchewan (IRR 0.75,
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p < 0.000, 95 % CI 0.70–0.80), Alberta (IRR 0.85,
p < 0.000, 95 % CI 0.82–0.89) and the Territories (IRR
0.43, p < 0.000, 95 % CI 0.33–0.56). For melanoma in
situ, different provincial patterns exist; several provinces
had IRRs significantly greater than British Columbia,
including Prince Edward Island, New Brunswick, Nova
Scotia and Alberta, while Quebec, Saskatchewan and the
Territories had IRRs markedly less than reference (e.g.,
Quebec [IRR 0.17, p < 0.000, 95 % CI 0.15–0.18]).
Incidence by urban/rural residence
Table 1 demonstrates the results of our analysis of mel-
anoma incidence by residence population density. For
invasive melanoma (again, excluding Ontario, but con-
trolling for age, sex and race), individuals living in rural
areas had incidence rates significantly less than individ-
uals in cities (IRR 0.82, p < 0.000, 95 % CI 0.79–0.85).
Similar results were seen for individuals living in towns
(IRR 0.82, p < 0.000, 95 % CI 0.79–0.85). Again, similar,
but more dramatic, differences were seen for in situ mel-
anoma; for rural residence, the incidence rate was 71 %
of that for cities (IRR 0.71, p < 0.000, 95 % CI 0.67–0.75)
and for towns, the incidence rate was 69 % of that for
cities (IRR 0.69, p < 0.000, 95 % CI 0.65–0.74). Reintrodu-
cing Ontario into the analysis did not significantly
change these results.
Table 1 Incidence rate ratios of the diagnosis of melanomaa (excludes Ontario)b
All melanoma (n = 105,681) In situ Invasive
IRR P value 95 % CI IRR P value 95 % CI IRR P value 95 % CI
Place of residence
City (census metropolitan area) 1 1 1
Town (census agglomeration) 0.80 0.00 (0.77–0.82) 0.69 0.00 (0.65–0.74) 0.82 0.00 (0.79–0.85)
Rural 0.80 0.00 (0.78–0.82) 0.71 0.00 (0.67–0.75) 0.82 0.00 (0.79–0.85)
Income quintile
Highest 1 1 1
2nd highest 0.89 0.00 (0.86–0.91) 0.86 0.00 (0.81–0.92) 0.89 0.00 (0.86–0.92)
Middle 0.85 0.00 (0.83–0.88) 0.79 0.00 (0.74–0.85) 0.86 0.00 (0.83–0.90)
2nd lowest 0.83 0.00 (0.81–0.86) 0.76 0.00 (0.71–0.82) 0.85 0.00 (0.82–0.88)
Lowest 0.79 0.00 (0.76–0.81) 0.68 0.00 (0.62–0.73) 0.82 0.00 (0.78–0.85)
Census year
2006 1.67 0.00 (1.62–1.73) 2.36 0.00 (2.17–2.57) 1.52 0.00 (1.46–1.59)
2001 1.10 0.00 (1.07–1.13) 1.38 0.00 (1.28–1.49) 1.05 0.02 (1.01–1.09)
1996 1.01 0.61 (0.98–1.04) 1.09 0.02 (1.01–1.18) 1.00 0.89 (0.96–1.03)
1991 1 1 1
Province
Newfoundland and Labrador 0.67 0.00 (0.63–0.72) 0.73 0.00 (0.63–0.84) 0.66 0.00 (0.61–0.71)
Prince Edward Island 1.16 0.00 (1.06–1.26) 1.59 0.00 (1.31–1.92) 1.07 0.26 (0.95–1.20)
Nova Scotia 1.12 0.00 (1.08–1.17) 1.65 0.00 (1.52–1.79) 1.00 0.94 (0.95–1.05)
New Brunswick 0.99 0.69 (0.95–1.04) 1.20 0.00 (1.08–1.32) 0.94 0.04 (0.89–1.00)
Quebec 0.39 0.00 (0.37–0.40) 0.17 0.00 (0.15–0.18) 0.44 0.00 (0.42–0.45)
Ontario b b b
Manitoba 0.78 0.00 (0.75–0.81) 0.90 0.03 (0.83–0.99) 0.74 0.00 (0.70–0.78)
Saskatchewan 0.74 0.00 (0.71–0.78) 0.69 0.00 (0.61–0.77) 0.75 0.00 (0.71–0.80)
Alberta 0.95 0.00 (0.92–0.98) 1.36 0.00 (1.27–1.45) 0.85 0.00 (0.82–0.89)
British Columbia 1 1 1
Territories 0.45 0.00 (0.37–0.57) 0.55 0.02 (0.34–0.90) 0.43 0.00 (0.33–0.56)
CI confidence interval, IRR incidence rate ratio
aNegative binomial regressions on the incidence of diagnosed cases of melanoma by dissemination area (DA) and census year. Regressions include detailed
controls for the age/sex composition of the DA as well as controls for the proportions of adults in the DA who are 1) black, 2) South Asian, 3) other Asian and 4)
other visible minority groups
bCases of in situ melanoma are not available for Ontario in the Canadian Cancer Registry dataset in the Statistics Canada Research Data Centre so Ontario DAs are
excluded from these regressions
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Discussion
Our study confirmed that within Canada, like in other
developed countries, the incidence of melanoma has
risen dramatically in the 15 years spanned by these data
[1–7]. Interestingly, our data showed that the rate of in-
crease in melanoma incidence has accelerated between
the 2001 and 2006 CYs. Multiple factors have been at-
tributed to this overall rise in melanoma incidence, in-
cluding depletion of the ozone layer (and its attendant
protection from solar ultraviolet-B radiation) [1]. In
addition, societal attitudes toward tanning have changed
over the past several decades, with an increased associ-
ation between tanned skin and physical attractiveness.
The availability of tanning beds, and the exposure to
them among young people, has also been associated with
an increase in the incidence of melanoma [11, 12]. An
increase in leisure time in developed societies is thought
to have led to more vacations spent in southern climes
as well as an increase in outdoor tanning [22]. The in-
creased aging of our population also is likely a factor in
higher melanoma rates [17, 18].
Other authors have pointed to changing criteria for
the diagnosis of melanoma, which have increased the
number of melanomas being diagnosed. Weyers et al. re-
fers to this increase in melanoma incidence as a “pseudoe-
pidemic,” and argues that melanomas are being detected
now that would otherwise have regressed naturally [28].
An increased awareness about melanoma screening has
led to cases being diagnosed at earlier stages; this was il-
lustrated in our data by the fact that the increase in inci-
dence for melanoma in situ was substantially larger than
that of melanoma as a whole.
The second finding in our study was a strong associ-
ation between higher SES and increased melanoma inci-
dence. This association between high SES and higher
incidence of melanoma is likely also multifactorial, as
many of the explanations for the increased incidence of
melanoma may impact individuals of different socioeco-
nomic status differently [10, 19–21, 24]. Factors like ac-
cess to tanning beds, vacation travel to warmer climates
and the availability of leisure time, which may be spent
sunbathing, are plausibly more prevalent in individuals
Table 2 Incidence rate ratios of the diagnosis of melanomaa (excludes Ontario)b–other controls
All melanoma (n–105,681) In situ Invasive
IRR P value 95 % CI IRR P value 95 % CI IRR P value 95 % CI
Proportion of Population by age/sex
Male 20–29 1 1 1
Male 30–39 0.99 0.01 (0.99–1.00) 0.98 0.01 (0.97–0.99) 1.00 0.25 (0.99–1.00)
Male 40–49 0.99 0.00 (0.98–0.99) 0.98 0.01 (0.97–1.00) 0.99 0.01 (0.98–1.00)
Male 50–59 0.99 0.01 (0.99–1.00) 0.99 0.48 (0.98–1.01) 0.99 0.02 (0.98–1.00)
Male 60–69 1.00 0.42 (0.99–1.01) 1.00 0.99 (0.98–1.02) 0.99 0.34 (0.98–1.01)
Male 70–79 1.01 0.00 (1.01–1.02) 1.01 0.32 (0.99–1.03) 1.01 0.00 (1.01–1.02)
Male 80+ 1.02 0.00 (1.02–1.03) 1.04 0.00 (1.02–1.06) 1.02 0.00 (1.01–1.03)
Female 20–29 0.99 0.07 (0.99–1.00) 0.99 0.04 (0.97–1.00) 1.00 0.23 (0.99–1.00)
Female 30–39 1.00 0.56 (0.99–1.00) 1.00 0.91 (0.99–1.01) 1.00 0.39 (0.99–1.00)
Female 40–49 1.01 0.00 (1.01–1.02) 1.02 0.01 (1.00–1.03) 1.01 0.00 (1.01–1.02)
Female 50–59 1.02 0.00 (1.01–1.03) 1.03 0.00 (1.01–1.04) 1.02 0.00 (1.01–1.02)
Female 60–69 1.02 0.00 (1.01–1.03) 1.02 0.09 (1.00–1.04) 1.02 0.00 (1.01–1.03)
Female 70–79 1.01 0.00 (1.01–1.02) 1.02 0.01 (1.00–1.03) 1.01 0.00 (1.01–1.02)
Female 80+ 1.01 0.00 (1.00–1.01) 1.00 0.70 (0.99–1.01) 1.01 0.00 (1.01–1.01)
Proportion of Population by race
White 1 1 1
Black 0.91 0.00 (0.88–0.95) 0.81 0.00 (0.73–0.89) 0.93 0.00 (0.90–0.97)
East/Southeast Asian 0.91 0.00 (0.90–0.92) 0.88 0.00 (0.86–0.91) 0.92 0.00 (0.90–0.93)
South Asian 0.88 0.00 (0.87–0.90) 0.90 0.00 (0.86–0.94) 0.88 0.00 (0.86–0.90)
Other groups 0.98 0.09 (0.95–1.00) 0.99 0.69 (0.92–1.05) 0.98 0.16 (0.95–1.01)
CI confidence interval, IRR incidence rate ratio
aNegative binomial regressions on the incidence of diagnosed cases of melanoma by dissemination area (DA) and census year. Table presents regression results
for control variables not reported in Table 1
bCases of in situ melanoma are not available for Ontario in the Canadian Cancer Registry dataset in the Statistics Canada Research Data Centre so Ontario DAs are
excluded from these regressions
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from more advantaged socioeconomic circumstances. It
is even plausible that attitudes about physical attractive-
ness and sun tanning are different between different so-
cioeconomic strata. Many studies have also shown that
awareness of, and access to, screening for cancer is dis-
proportionately higher in individuals with higher SES
[29]. Individuals of higher SES may be more likely to see
a dermatologist and to investigate abnormal pigmented
lesions. It should be noted that the effects of race on
SES and melanoma incidence may represent an import-
ant confounder; we did attempt to eliminate the possibil-
ity of such confounding by including race in our logistic
regression analysis.
The third finding in our study was a higher incidence
of melanoma, even when controlling for SES and other
factors, in urban residents of Canada. Our own previous
study with thyroid cancer, another malignancy frequently
detected during screening exams, found that urban resi-
dence (rather than in towns or rural areas) correlates
with increased detection of cancer in Canada [26]. This
may be due to access to a physician in general or more
specifically to a dermatologist. Di Quinzio et al found
that family physician visits correlated with earlier stage
melanoma [30]. Certainly, dermatologists are typically
concentrated in urban centers in Canada, and patients
may be more likely to be referred to a specialist such as
a dermatologist regarding suspicious pigmented lesions
if they live in an urban area. Whether individuals who
live in cities spend more time in the sun than town or
rural residents is unclear at present.
Finally, our study found substantial discrepancies in
melanoma incidence across different Canadian prov-
inces. This is similar to what was previously found by
Gaudette and Gao [31]. Further studies are needed to
help elucidate the reasons for this large discrepancy, but
access to screening for melanoma and access to special-
ists such as dermatologists may also differ from province
to province, in the same way that they differ for urban
and rural residences.
Our study had several important limitations. Not all
data for the incidence of melanoma was available in some
provinces, and in situ data was not available for Ontario.
Second, while we did control for race using the techniques
described, race was not included in the Canadian Cancer
Registry data. Thirdly, we similarly do not possess data
within the Canadian Cancer Registry on such important
characteristics as tanning bed use, time spent in sun or
awareness of/access to screening tests for melanoma on
the individual level. Finally, our data is only up until 2006,
as the long form census was not used in 2011.
Conclusions
The incidence of melanoma rose significantly in our study
from 1992 to 2006; this rise was most striking in
melanoma in situ. Individuals with higher SES and pa-
tients in urban centers had significantly higher incidence
rates of melanoma than individuals with lower SES or
who resided in towns or rural areas. Finally, there were
differences, in some cases quite dramatic, between the
various provinces of Canada with respect to melanoma
incidence.
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